novel therapies for future challenges 2. circular€¦ · novel therapies for future challenges 2....

Annual Meeting of the German Pharmaceutical Society – DPhG

Novel Therapies forFuture Challenges

2. Circular

saarbrücken, Germanyseptember 26 – 29, 2017at saarland university

Welcome Address

Dear colleagues,the President of the German Pharmaceutical society (dPhG) and the congress chairman would like to invite you to saarbrücken, Germany, in september to attend our annual dPhG meeting 2017. With this year‘s meeting we would like to focus on novel therapies for future challenges. This topic has found its expression in the structure and contents of the many sessions and lectures of the 2017 meeting, where we aim to address future challenges in interdisciplinary as well as in focused sessions within each pharmaceutical discipline.

We are looking forward to welcoming you and your co-workers in saarbrücken. Poster contributions and the pertaining interaction of younger scientists with other attendees are a major part of the annual dPhG meeting. We will therefore schedule a dedicated oral poster presentation session for Phd students and will provide generous time for poster sessions. Furthermore, we will offer “prime time” sessions for our excellent young postdocs and group leaders who have not yet received a professor position and need our full attention to secure growth and sustainability of academic pharmaceutical science in the future.

Best wishes for a fruitful meeting with intensive scientific exchange and discussions!

Prof. Dr. Thorsten Lehr congress chairman

Prof. Dr. Stefan Laufer dPhG-President

P

P

P

D

B C

E

A

E72

E8 1

E71

E31

E29

E28

E27

E26

E25

E24

E22

Uni Nord

Uni Ost

Uni Mitte

E21

E23

E16

E17

E15

E14E13

E12E11

E91

D45

D43

D51

D44

D41

D32

D33 D34

D31

D25D24

D23

D22D21D12

D11

C81

C83

C82

C91C9 2

C77

C76C75

C74

C73C72

C71

C65

C64

C63 C62C55

C54C53

C52C51

C48

C45

C44

C43C42 C41C31

C22 C23C21

C13

C12

C11

C93

B83

B82 B81

B32

B33

B31

B22B21

B73

B72

B71

B68 B66

B65

B64

B63

B62

B61 B52

B51

B44

B43

B42

B41

B12 B11

A54

A53

A52

A51

A44

A43A42

A41

A33

A32A31

A24

A23

A22

A17

A15

A14

A13

A12

A11

venue

The Congress will take place at saarland university, campus e22 and e25, 66123 saarbrücken.

Travelling to the university by train and bushigh-speed ice/TGv services are available from Frankfurt/mannheim and Paris to saarbrücken central station. regional services run from mainz, Trier and strasbourg.

To get from saarbrücken central station to the uni-versity campus (30 minutes), take either bus number 102 (to ‚dudweiler-dudoplatz‘) or bus numbers 112 or 124 (to ‚universität‘). These services run every 30 minutes. There are several bus stops on campus. Bus stop ‚universität mensa‘ ist the closest bus stop for the annual meeting. For further information please contact:

http://www.uni-saarland.de/en/footer/dialogue/find-us/saarbruecken.html

©saarland university

dAy 1WednesdAy, sePTemBer 27locATion: sAArlAnd universiTy, cAmPus e22 And e25, 66123 sAArBrücken

13.00 -13.45 opening of the Annual dPhG meeting 2017 Award session

13.45 -14.30 Plenary lecture 1

14.30 -15.00 coffee break / Posters

15.00 -16.30

3 PARALLEL SESSIONS

Therapeutic potential of nucleic acids(Chairs: Christian Ducho, Alexandra Kiemer)

Natural compounds as tools and leads(Chair: Harald Groß)

Innovations in dermal delivery(Chairs: Dagmar Fischer, Peter Langguth)


17.30 -18.45 meetings der dPhG-Fachgruppen

19.00 -21.30 PosTer vieWinG / Welcome recePTion

Please find detailed information on the annual meetingon the conference website: www.2017.dphg.de

CONFIRMED PLENARy SPEAkERS(For speakers order please check final programme on website)

Gunda I. Georg, university of minnesotaChristopher J. Schofi eld, university of oxfordHelge B. Bode, Goethe university FrankfurtMolly Stevens, imperial college londonMeindert Danhof, leiden universityHans H. Maurer, saarland university

dAy 2 ThursdAy, sePTemBer 28 locATion: sAArlAnd universiTy, cAmPus e22 And e25, 66123 sAArBrücken

08.30 -10.00 3 PARALLEL SESSIONS


Antiviral therapy (Chair: Christian Klein)

New antibiotics (Chair: Rolf W. Hartmann)

Tissue engineering (Chair: Torsten Blunk)

Intracellular ion channels as drug targets (Chair: Veit Flockerzi)

Translational systems pharmacology in drug development and therapeutic use (Chairs: Charlotte Kloft, Meindert Danhof)

Medication safety research (Chairs: Ulrich Jaehde, Martin Hug)


Session “Arzneimittelkontrolle” Fast in vitro/in vivo testing (Chairs: Hermann Wätzig, Klaus Raith)

Session “Arzneimittelkontrolle” Clean rooms (Chairs: Hermann Wätzig, Klaus Raith)

10.00 - 10.30 coffee break / Posters

15.45 - 16.15 coffee break / Posters

10.30 - 11.45 Poster short talks (Plenary)

16.15 - 17.00 Plenary lecture 4

11.45 - 13.15 lunch break

17.30 - 19.00 dPhG-hauptversammlung

13.15 - 14.00 Plenary lecture 3

19:30 conference dinner (ratskeller)

CONFIRMED PLENARy SPEAkERS (For speakers order please check final programme on website)

Gunda I. Georg, university of minnesota Christopher J. Schofield, university of oxford Helge B. Bode, Goethe university Frankfurt Molly Stevens, imperial college london Meindert Danhof, leiden university Hans H. Maurer, saarland university

dAy 3 FridAy, sePTemBer 29 locATion: sAArlAnd universiTy, cAmPus e22 And e25, 66123 sAArBrücken

12.00 -13.00 lunch



14.30 - 15.15 Award session and closing ceremony


10.00 -10.30 coffee break / Posters


Metabolic diseases (til 9:45) (Chairs: Oliver Werz, Dieter Steinhilber)

Nanomedicine (Chairs: Claus-Michael Lehr, Marc Schneider)

New research, new researchers I (Chair: Andreas Link)


Academic drug discovery - ficts, facts or fantasy? (from 10:15) (Chair: Stefan Laufer)

Lipidomics (Chairs: Oliver Werz, Dieter Steinhilber)

New research, new researchers II (Chair: Andreas Link)

Session “Arzneimittelkontrolle” Bio- and bioinspired materials (Chairs: Hermann Wätzig, Klaus Raith)

CONFIRMED PLENARy SPEAkERS (For speakers order please check final programme on website)

Gunda I. Georg, university of minnesota Christopher J. Schofield, university of oxford Helge B. Bode, Goethe university Frankfurt Molly Stevens, imperial college london Meindert Danhof, leiden university Hans H. Maurer, saarland university

Pre-meeTinG ProGrAmmeTuesdAy, sePTemBer 26, 14.00 -18.00 uhr

BürgersymposiumGeschichte der Pharmazie in saarbrückenLeitung: Christoph Friedrich, MarburgOrt: seminarraum (raum 0.27) des helmholtz-instituts für Pharmazeutische Forschung saarland (hiPs),campus Gebäude e8.1

14.00 uhr Begrüßung durch den vorsitzenden der FGGeschichte der PharmazieProf. Dr. Christoph Friedrich, Marburg

14.15 uhr „Zur entwicklung des hochschulfaches Pharmazie an deruniversität saarbrücken“ Prof. Dr. Dr. h. c. Hans H. Maurer / Prof. Dr. Alexandra Kiemer, Saarbrücken

15.00 uhr „Zur entwicklung des Apothekenwesens in saarbrücken“Dr. Bernhard Müller, Waldfi schbach-Burgalben undSaarbrücken

15.45 uhr kaffeepause

16.15 uhr „Zur Geschichte der pharmazeutischen industrie insaarbrücken“Dr. Stefanie Boman-Degen, Osnabrück

17.00 uhr „‘nun lassen sie doch ihre spielereien mit den dünnenschichten, herr stahl!‘ – saarbrücken und diechromatographie“ Dr. Karl Conrath, Saarbrücken

ende der veranstaltung ca. 18 uhr


Programm

universität des saarlandes, Günter-hotz-hörsaal, Gebäude e 22Thema:„Arzneimitteltherapiesicherheit, Medikationsplan und Interprofessionelle kommunikation - wo wir stehen und wohin wir gehen (sollten)“

Beginn 15 uhr Begrüßung durch die veranstaltungskooperationsverteterder universität saarland, dPhG Fachgruppe Allgemeinpharmazie und Apothekerkammer saarland.

1. „interprofessionelle kommunikation und Arzneimittel-therapiesicherheit – oder – Wie reden Apotheke und Ärzte bei schweren Arzneimittelinteraktionen miteinander?“PD Dr. Guido Schmiemann, Institut für Public Health und Pfl egeforschung, Universität Bremen

PosT-meeTinG ProGrAmmesATurdAy, sePTemBer 30, 15.00 – 18.00 uhrTAG der oFFiZinPhArmAZie


informationen unter www.dphg.de/apo17

2. „Arzneimitteltherapiesicherheit – Warum sie nochimmer nicht den Patienten erreicht!“ Prof. Dr. Daniel Grandt, Klinik für Innere Medizin I,Klinikum Saarbrücken

kaffeepause 16:15 – 16:453. „medikationsplan – wo stehen wir?“

Dr. Hanna Seidling, Klinische Pharmakologie & Pharmakoepidemiologie, Universitäts Klinikum Heidelberg

4. Panel mit den referenten und Publikumsbeteiligungim Anschluss an die vorträge ab 18 uhr

5. im Anschluss mitgliederversammlung der Fachgruppe Allgemeinpharmazie

Tagesordnung:> Jahresbericht und Aktivitäten der Fachgruppe

Allgemeinpharmazie , herr dr. michael hannig> Wahl der Fachgruppenvorsitzenden

REGISTRATION FEE* uNTIL 31.07. LATE REGISTRATION

dPhG-members 220 M 290 M

non-members 390 M 490 Mmembers students 110 M 130 Mnon-members students 190 M 290 M

* Welcome reception on september 27 is included. For „Bürgersymposium“ (september 26), conference dinner at ratskeller (september 28) and hotel booking please refer to website: www.2017.dphg.de

die Teilnahme am Bürgersymposium ist kostenlos.

PLEASE REGISTER ONLINE: www.2017.dphg.de

dPhG e. v. | varrentrappstr. 40-42, 60486 Frankfurt am main Phone: +49 (0)69 71 91 59 60, Fax: +49 (0)69 71 91 59 629 e-mail: [email protected] registergericht Berlin-charlottenburg nr. 2737 B

submit abstracts until June 30th, see www.2017.dphg.de for details.

reGisTrATion


novel therapies for future challenges 2. circular€¦ · novel therapies for future challenges 2....

Documents